Alessio Fiascarelli

513 total citations
13 papers, 328 citations indexed

About

Alessio Fiascarelli is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Alessio Fiascarelli has authored 13 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Rheumatology. Recurrent topics in Alessio Fiascarelli's work include Enzyme Structure and Function (4 papers), Advanced Breast Cancer Therapies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Alessio Fiascarelli is often cited by papers focused on Enzyme Structure and Function (4 papers), Advanced Breast Cancer Therapies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Alessio Fiascarelli collaborates with scholars based in Italy, United States and Poland. Alessio Fiascarelli's co-authors include Roberto Contestabile, Alessandro Paiardini, Francesca Cutruzzolà, Giorgio Giardina, Marina Marani, Serena Rinaldo, Alessio Paone, Martino L. di Salvo, Alessandra Giorgi and Angela Tramonti and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Alessio Fiascarelli

11 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alessio Fiascarelli Italy	7	246	104	57	51	49	13	328
Karen J. Chave United States	11	184 0.7×	20 0.2×	47 0.8×	86 1.7×	140 2.9×	20	353
Joseph A. Combs United States	5	164 0.7×	76 0.7×	20 0.4×	73 1.4×	20 0.4×	7	311
S S Gong United States	12	236 1.0×	24 0.2×	20 0.4×	91 1.8×	34 0.7×	14	425
Zenia Nimec United States	13	246 1.0×	36 0.3×	22 0.4×	80 1.6×	113 2.3×	20	422
Tateki Suzuki Japan	12	506 2.1×	63 0.6×	25 0.4×	23 0.5×	3 0.1×	19	611
Srinivasan Rengachari Austria	9	365 1.5×	34 0.3×	16 0.3×	54 1.1×	4 0.1×	12	488
Marta Starczak Poland	10	270 1.1×	28 0.3×	11 0.2×	9 0.2×	26 0.5×	19	338
Ming C. Liau United States	13	376 1.5×	30 0.3×	18 0.3×	51 1.0×	138 2.8×	35	529
Marc N. Offman United Kingdom	7	190 0.8×	25 0.2×	21 0.4×	9 0.2×	21 0.4×	8	298
Chase Neumann United States	7	161 0.7×	99 1.0×	36 0.6×	60 1.2×	3 0.1×	8	286

Countries citing papers authored by Alessio Fiascarelli

Since Specialization

Citations

This map shows the geographic impact of Alessio Fiascarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessio Fiascarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessio Fiascarelli more than expected).

Fields of papers citing papers by Alessio Fiascarelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessio Fiascarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessio Fiascarelli. The network helps show where Alessio Fiascarelli may publish in the future.

Co-authorship network of co-authors of Alessio Fiascarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Alessio Fiascarelli. A scholar is included among the top collaborators of Alessio Fiascarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessio Fiascarelli. Alessio Fiascarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Bardia, Aditya, Javier Cortés, José Á. García-Sáenz, et al.. (2025). Abstract P1-01-25: Elacestrant vs SOC in ER+, HER2- advanced or metastatic breast cancer (mBC) with ESR1-mutated tumors: ESR1 allelic frequencies and clinical activity from the phase 3 EMERALD trial. Clinical Cancer Research. 31(12_Supplement). P1–1.

Zicari, Sonia, Giuseppe Merlino, Alessio Fiascarelli, et al.. (2024). The Dual PIM/FLT3 Inhibitor MEN1703 Combines Synergistically With Gilteritinib in FLT3‐ITD‐Mutant Acute Myeloid Leukaemia. Journal of Cellular and Molecular Medicine. 28(23). e70235–e70235. 1 indexed citations

Merlino, Giuseppe, et al.. (2023). Model‐based prediction of effective target exposure for MEN1611 in combination with trastuzumab in HER2‐positive advanced or metastatic breast cancer patients. CPT Pharmacometrics & Systems Pharmacology. 12(11). 1626–1639. 10 indexed citations

Merlino, Giuseppe, Alessio Fiascarelli, Patrizia Tunici, et al.. (2023). Abstract 2849: The oral SERD Elacestrant in combination with the PI3K inhibitor MEN1611 inhibits tumor growth in ER+/HER2- breast cancer in vitro and in PDX models. Cancer Research. 83(7_Supplement). 2849–2849. 1 indexed citations

Fiascarelli, Alessio, Giuseppe Merlino, Alessandro Bressan, et al.. (2023). Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer. Breast Cancer Research and Treatment. 199(1). 13–23. 5 indexed citations

Iannitto, Maria Luisa, Alessio Fiascarelli, Sonia Zicari, et al.. (2023). Tagraxofusp Shows Promising Anti-Tumoral Efficacy in Preclinical in Vitro Models of Myelofibrosis, Both As a Single Agent and in Combination with Janus Kinase Inhibitors. Blood. 142(Supplement 1). 6329–6329.

Merlino, Giuseppe, Alessio Fiascarelli, Mario Bigioni, et al.. (2018). Abstract 2160: MEN1611, a novel α-selective PI3K inhibitor in solid tumors. Cancer Research. 78(13_Supplement). 2160–2160. 5 indexed citations

Paiardini, Alessandro, Angela Tramonti, Martino L. di Salvo, et al.. (2016). Differential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogramming. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1864(11). 1506–1517. 34 indexed citations

Paiardini, Alessandro, Alessio Fiascarelli, Serena Rinaldo, et al.. (2015). Screening and In Vitro Testing of Antifolate Inhibitors of Human Cytosolic Serine Hydroxymethyltransferase. ChemMedChem. 10(3). 490–497. 26 indexed citations

10.

Tramonti, Angela, Alessio Fiascarelli, Teresa Milano, et al.. (2015). Molecular mechanism of PdxR – a transcriptional activator involved in the regulation of vitamin B₆ biosynthesis in the probiotic bacterium Bacillus clausii. FEBS Journal. 282(15). 2966–2984. 31 indexed citations

11.

Giardina, Giorgio, Alessio Fiascarelli, Maurício G. S. Costa, et al.. (2015). How pyridoxal 5′‐phosphate differentially regulates human cytosolic and mitochondrial serine hydroxymethyltransferase oligomeric state. FEBS Journal. 282(7). 1225–1241. 76 indexed citations

12.

Marani, Marina, Alessio Paone, Alessio Fiascarelli, et al.. (2015). A pyrazolopyran derivative preferentially inhibits the activity of human cytosolic serine hydroxymethyltransferase and induces cell death in lung cancer cells. Oncotarget. 7(4). 4570–4583. 45 indexed citations

13.

Paone, Alessio, Marina Marani, Alessio Fiascarelli, et al.. (2014). SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation. Cell Death and Disease. 5(11). e1525–e1525. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact